The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature

Around the world, about 15 to 40% of individuals with inflammatory bowel disease (IBD) rely on cannabis and cannabinoids to reduce the need for other medications, as well as increase appetite and reduce pain. Whereas more and more patients continue to report benefits accruing from cannabis and canna...

Descripción completa

Detalles Bibliográficos
Autores principales: Nduma, Basil N, Mofor, Kelly A, Tatang, Jason, Ekhator, Chukwuyem, Ambe, Solomon, Fonkem, Ekokobe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101654/
https://www.ncbi.nlm.nih.gov/pubmed/37065370
http://dx.doi.org/10.7759/cureus.36148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101654/
https://www.ncbi.nlm.nih.gov/pubmed/37065370
http://dx.doi.org/10.7759/cureus.36148

Ejemplares similares